This recognition highlights their long-standing contributions to the field of gastronterology and hepatology, reflecting both the depth and consistency of their scientific work over time. Appearing in both the career-long and recent-year lists, our researchers exemplify how sustained dedication to research continues to resonate across the global scientific community.

Richard Moreau, Director of EF CLIF, has built a career marked by influential discoveries in clinical hepatology. Jonel Trebicka, Deputy Director, is recognized for his innovative research, bridging translational insights and patient care. Joan Clària, Head of Translational Operations, continues to advance the understanding of chronic liver disease through impactful translational studies.

All three are affiliated with leading institutions — including INSERM, University Hospital Münster, and Hospital Clinic de Barcelona — underscoring EF CLIF’s position as a hub of internationally recognized hepatology research. Their presence on the ranking demonstrates not only past achievements but also ongoing relevance, as they continue to guide new investigations and mentor the next generation of scientists.

“Being recognized among the top 2% most cited scientists worldwide is a testament to the sustained impact of our research team, and it reflects the collaborative spirit that drives EF CLIF’s mission”, said Richard Moreau.

This recognition adds to EF CLIF’s legacy of scientific excellence, reaffirming the foundation’s role at the forefront of chronic liver disease research and its continued influence on the field of hepatology globally.